Abstract
Krox-24 (NGFI-A, Egr-1) is an immediate-early gene encoding a zinc finger transcription factor. As Krox-24 is expressed in brain areas showing post-natal neurogenesis during a thyroid hormone (T3)-sensitive period, we followed T3 effects on Krox-24 expression in newborn mice. We analysed whether regulation was associated with changes in mitotic activity in the subventricular zone and the cerebellum. In vivo T3-dependent Krox-24 transcription was studied by polyethylenimine-based gene transfer. T3 increased transcription from the Krox-24 promoter in both areas studied at post-natal day 2, but was without effect at day 6. An intact thyroid hormone response element (TRE) in the Krox-24 promoter was necessary for these inductions. These stage-dependent effects were also seen in endogenous Krox-24 mRNA levels: activation at day 2 and no effect at day 6. Moreover, similar results were obtained by examining β-galactosidase expression in heterozygous mice in which one allele of the Krox-24 gene was disrupted with an in-frame Lac-Z insertion. However, bromodeoxyuridine incorporation showed mitosis to continue through to day 6. We conclude first, that T3 activates Krox-24 transcription during early post-natal mitosis but that this effect is extinguished as development proceeds and second, loss of T3-dependent Krox-24 expression is not correlated with loss of mitotic activity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abdallah B, Hassan A, Benoist C, Goula D, Behr JP and Demeneix BA. . 1996 Hum. Gene Ther. 7: 1947–1954.
Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA and Struhl K. . 1994 In Current Protocols in Molecular Biology. John Wiley & Sons, Inc., New York. pp. 1.7.9–1.7.10.
Boussif O, Lezoualc'h F, Zanta M, Mergny MD, Demeneix B and Behr JP. . 1995 Proc. Natl. Acad. Sci. USA 92: 7297–7301.
Bradley D, Towle H and Young WS. . 1992 J. Neurosci. 6: 2288–2302.
Christy BA and Nathans D. . 1989 Proc. Natl. Acad. Sci. USA 86: 8737–8741.
Demeneix BA and Henderson NE. . 1978 Gen. Comp. Endoc. 35: 77–85.
Forrest D. . 1995 Semin. Cancer Biol. 5: 167–176.
Gashler AL and Sukhatme VP. . 1995 Prog. Nucleic. Acid Res. Mol. Biol. 50: 191–224.
Ghorbel M, Seugnet I, Ableitner AM, Hassan A and Demeneix BA. . 1997 Neurosci. Lett. 231: 127–130.
Gius D, Cao XM, Rauscher 3rd FJ, Cohen DR, Curran and Sukhatme VP. . 1990 Mol. Cell. Biol. 10: 4243–4255.
Glass CK. . 1994 Endoc. Rev. 15: 391–407.
Glass CK, Lipkin SM, Devary OV and Rosenfeld MG. . 1989 Cell 59: 697–708.
Guissouma H, Ghorbel MT, Seugnet I, Ouatas T and Demeneix BA. . FASEB J. In press.
Koenig R, Lazar M, Hodin R, Brent G, Larsen P, Chin W and Moore D. . 1989 Nature 337: 659–661.
Lebel JM and Dussault JH. . 1994 Curr. Opin. Endocrin. Diab. 1: 167–174.
Lee SL, Tourtellotte LC, Wesselschmidt RL and Milbrandt J. . 1995 J. Biol. Chem. 270: 9971–9977.
Lee SL, Wang Y and Milbrandt J. . 1996 Mol. Cell Biol. 16: 4566–4572.
Lemaire P, Relevant O, Bravo R and Charnay P. . 1988 Proc. Natl. Acad. Sci. USA 85: 4691–4695.
Lezoualc'h F, Hassan AHS, Giraud P, Loeffler JP, Lee SL and Demeneix BA. . 1992 Mol. Endocrinol. 6: 1797–1804.
Luskin MB. . 1993 Neuron 11: 173–189.
Mellström B, Pipaon C, Naranjo JR, Perez-Castillo A and Santos A. . 1994 Endocrinology 135: 583–588.
Milbrandt J. . 1987 Science 238: 797–799.
Nicholson JL and Altman J. . 1972 Brain Res. 44: 13–23.
Pipaon C, Santos A and Perez-Castillo A. . 1992 J. Biol. Chem. 267: 21–23.
Raff MC. . 1992 Nature 356: 397–400.
Rohrer H. . 1990 Eur. J Neuroscience 2: 1005–1015.
Seed B and Sheen J-Y. . 1988 Gene 67: 271–277.
Sukhatme VP, Cao X, Chang LC, Tsai-Morris CH, Stemenkovich D, Ferreira PCP, Cohen R, Edwards SA, Shows TB, Curran T, Le Beau MM and Adamson E. . 1988 Cell 53: 37–43.
Sukhatme VP, Kartha S, Toback FG, Taub R, Hoover RG and Tsai-Morris CH. . 1987 Oncogene Res. 1: 343–355.
Topilko P, Schneider-Maunoury S, Levi G, Trembleau A, Gourdji D, Driancourt M-A, Rao CV and Charnay P. . 1997 Mol. Endocrinol. 12: 107–122.
Tsai-Morris CH, Cao X and Sukhatme VP. . 1988 Nucleic. Acids Res. 16: 8835–8846.
Wolffe AJ. . 1997 Nature 383: 16–17.
Zhu N, Liggitt D, Liu Y and Debs R. . 1993 Science 261: 209–211.
Acknowledgements
We are greatly indebted to Dr P Charnay (INSERM, ENS, Paris) for his generous gift of Krox-24+/− mutant mice. We thank the Association pour la Recherche contre le Cancer (ARC), the Association Française contre les Myopathies (AFM), the Association pour la Recherche sur la Sclerose en Plaque (ARSEP) and AIRC for financial support. MTG was a recipient of predoctoral scholarships from ARC, Ligue Contre le Cancer and the FRM.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ghorbel, M., Seugnet, I., Hadj-Sahraoui, N. et al. Thyroid hormone effects on Krox-24 transcription in the post-natal mouse brain are developmentally regulated but are not correlated with mitosis. Oncogene 18, 917–924 (1999). https://doi.org/10.1038/sj.onc.1202378
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202378
Keywords
This article is cited by
-
Effects of Hypoxic Preconditioning on Expression of Transcription Factor NGFI-A in the Rat Brain after Unavoidable Stress in the “Learned Helplessness” Model
Neuroscience and Behavioral Physiology (2010)
-
Thyroid hormone regulates the expression of SNAP-25 during rat brain development
Molecular and Cellular Biochemistry (2007)
-
Action of thyroid hormone in brain
Journal of Endocrinological Investigation (2002)